Contrast-Free Ultrasound Microvascular Imaging via Radiality and Similarity Weighting

Microvascular imaging has advanced significantly with ultrafast data acquisition and improved clutter filtering, enhancing the sensitivity of power Doppler imaging to small vessels. However, the image quality remains limited by spatial resolution and elevated background noise, both of which impede visualization and accurate quantification. To address these limitations, this study proposes a high-resolution cross-correlation Power Doppler (HR-XPD) method that integrates spatial radiality weighting with Doppler signal coherence analysis, thereby enhancing spatial resolution while suppressing artifacts and background noise. Quantitative evaluations in simulation and in vivo experiments on healthy human liver, transplanted human kidney, and pig kidney demonstrated that HR-XPD significantly improves microvascular resolvability and contrast compared to conventional PD. In vivo results showed up to a 2 to 3-fold enhancement in spatial resolution and an increase in contrast by up to 20 dB. High-resolution vascular details were clearly depicted within a short acquisition time of only 0.3 s-1.2 s without the use of contrast agents. These findings indicate that HR-XPD provides an effective, contrast-free, and high-resolution microvascular imaging approach with broad applicability in both preclinical and clinical research.

Optimizing In Vivo Data Acquisition for Robust Clinical Microvascular Imaging Using Ultrasound Localization Microscopy

Ultrasound localization microscopy (ULM) enables microvascular imaging at spatial resolutions beyond the acoustic diffraction limit, offering significant clinical potentials. However, ULM performance relies heavily on microbubble (MB) signal sparsity, the number of detected MBs, and signal-to-noise ratio (SNR), all of which vary in clinical scenarios involving bolus MB injections. These sources of variations underscore the need to optimize MB dosage, data acquisition timing, and imaging settings in order to standardize and optimize ULM of microvasculature. This pilot study investigated temporal changes in MB signals during bolus injections in both pig and human models to optimize data acquisition for clinical ULM. Quantitative indices were developed to evaluate MB signal quality, guiding selection of acquisition timing that balances the MB localization quality and adequate MB counts. The effects of transmitted voltage and dosage were also explored. In the pig model, a relatively short window (approximately 10 seconds) for optimal acquisition was identified during the rapid wash-out phase, highlighting the need for real-time MB signal monitoring during data acquisition. The slower wash-out phase in humans allowed for a more flexible imaging window of 1-2 minutes, while trade-offs were observed between localization quality and MB density (or acquisition length) at different wash-out phase timings. Guided by these findings, robust ULM imaging was achieved in both pig and human kidneys using a short period of data acquisition, demonstrating its feasibility in clinical practice. This study provides insights into optimizing data acquisition for consistent and reproducible ULM, paving the way for its standardization and broader clinical applications.